~~<i id='3327EF78A2'><strike id='3327EF78A2'><tt id='3327EF78A2'><pre id='3327EF78A2'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

explore

author：hotspot 2025-10-01 01:50:31 - browse：751

The Food and Drug Administration on Thursday approved a gene therapy to treat people with hemophilia A, an inherited and rare bleeding disorder.

The treatment, called Roctavian, is made by BioMarin Pharmaceutical. It was first approved in Europe in August 2022.

Roctavian is a one-time therapy that, in clinical trials, dramatically reduced bleeding episodes and helped patients live without the blood transfusions used to treat the disease. The FDA first rejected Roctavian in 2020, asking BioMarin to amass more data on its safety and long-term durability, and then delayed its decision again to account for additional evidence.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How one medical school became remarkably diverse
Next article： HIV vaccine remains elusive. Immunologists keep trying new ideas

focus

leisure time

Wikipedia

knowledge

entertainment

focus

John-ArneRøttingenistheheadoftheWellcomeTrust,oneoftheworld’stopprivatefundersofbiomedicalresearch.I

WSS

American woman, child freed after being kidnapped in Haiti last month

Glen Campbell's doctor discusses his public struggle with Alzheimer's

FDA panel issues narrow recommendation for Covid vaccine booster doses

Shkreli is convicted of fraud. Can pharma finally slam the door on him?

Drastic changes should bring profitability, startup health insurers say

American woman, child freed after being kidnapped in Haiti last month

leisure time

explore

focus

United colonoscopy coverage change 'may cost lives,' doctors say

A biotech analyst on neuroscience, placebo effect, not over

Jerome Adams on the need for new antivirals for Covid

It's time to retire 'poor historian' from clinicians' vocabularies

Walensky prepares to leave CDC — and Congress — behind

Friends ask where James Watson's attitudes about race came from

Anesthesiologist group: stop taking Ozempic before surgery

The best solution to the drug shortages problem

Walensky prepares to leave CDC — and Congress — behind

South Korea throws huge K

leisure time

Maui's cultural, historic landmarks damaged in the devastating wildfires

NIH trials fail to test meaningful long Covid therapies, experts say

Wayne Brady comes out as pansexual: 'Free to love whomever I want'

South Korea throws huge K

NIH trials fail to test meaningful long Covid therapies, experts say

Criminal prosecution for violating HIPAA: an emerging threat

Wikipedia

knowledge

entertainment

focus